Muscle regeneration: Molecular aspects and therapeutic implications

Current Opinion in Neurology

Volumn 12, Issue 5, 1999, Pages 535-543

  Grounds, Miranda D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CLENBUTEROL; DEFLAZACORT; FIBROBLAST GROWTH FACTOR; ISOPRENALINE; LEUKEMIA INHIBITORY FACTOR; LIOTHYRONINE; NANDROLONE DECANOATE; NAPROXEN; PREDNISOLONE; PROPRANOLOL; SOMATOMEDIN;

ANIMAL MODEL; BONE MARROW CELL; GENETIC ENGINEERING; HUMAN; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOBLAST; NONHUMAN; RAT; REPORTER GENE; REVIEW; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; HUMANS; MUSCLES; MUSCULAR DYSTROPHIES; REGENERATION;

EID: 0033388867     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199910000-00007     Document Type: Review

References (101)

1. 1 Grounds MD, McGeachie JK. Therapeutic uses of muscle and factors controlling the efficiency of whole muscle graft regeneration, In: Composite tissue transplantation. Hewitt CE, Black K (editors). Texas: RG Landes Bioscience Co.; 1999. pp. 121-137.
2. 2 Thorsson O, Rantanen J, Hurme T, Kalimo H. Effects of nonsteroidal antiinflammatory medication on satellite cell proliferation during muscle regeneration. Am J Sports Med 1998; 26:172-176.
3. 3 Rantanen J, Thorsson O, Wollmer P, Hurme T, Kalimo H. Effects of therapeutic ultrasound on the regeneration of skeletal myofibers after experimental muscle injury. Am J Sports Med 1999; 27:54-59.
4. 4 Vandenburgh H, Chromiak J, Shansky J, Del Tatto M, Lemaire J. Space travel directly induces skeletal muscle atrophy. FASEB J 1999; 13:1031-1038.
5. 5 Clark KM, Bindoff LA, Lightowlers RN, Andrews RM, Griffiths PG, Johnson MA, et al. Reversal of a mitochondrial DNA defect in human skeletal muscle. Nature Genet 1997; 16:222-224.
6. 6 Anderson JE. Studies of the dynamics of skeletal muscle regeneration: the mouse came back! Biochem Cell Biol 1998; 76:13-26.
7. 7 Pavlath G, Thaloor D, Rando T, Cheong M, English A, Zheng B. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev Dyn 1998; 212:495-508.
8. 8 Houstava L, Dubovy P, Haninec P, Grim M. An alternative preparation of the acellular muscle graft for reconstruction of the injured nerve: morphological analysis. Ann Anat 1999; 181:75-281.
9. 9 Grounds MD. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Towards prolongation of the healthy life span: practical approaches to intervention. Ann NY Acad Sci 1998; 854:78-91.
10. 10 Musaro A, Rosenthal N. Transgenic mouse models of muscle aging. 1999; 34:147-156.
11. 11 Cannon JG, Pierre BA. Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem 1998; 179:159-167.
12. 12 Carlson BM, Faulkner JA. Muscle regeneration in young and old rats: effects of motor nerve transection with and without marcaine treatment. J Gerontol A Biol Sci Med Sci 1998; 53:B52-B57.
13. 13 Luff AR. Age-associated changes in the innervation of muscle fibres and changes in the mechanical properties of motor units. Ann NY Acad Sci 1998; 854:92-101.
14. 14 Lescaudron L, Peltekian E, Fontaine-Perus J, Paulin D, Zampieri M, Garcia L, et al. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromusc Disord 1999; 9:72-80.
15. 15 Thaloor D, Miller K, Gephart J, Mitchell PO, Pavlath GK. Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol (Cell Physiol) 1999; 277:C320-C329.
16. 16 Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2:549-558.
17. 17 Nash A, Kurek J, Hilton D. Cytokines: from the laboratory to the clinic. Drug Dev Res 1999; 46:197-205.
18. 18 Partridge T, Lu QL, Morris G, Hoffman E. Is myoblast transplantation effective? Nature Med 1998; 4:1208-1209.
19. 19 Greelish JP, Su LT, Lankford EB, Burkman JM, Chen H, Konig SK, et al. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nature Med 1999; 5:439-443.
20. 20 Bou-Gharios G, Wells DJ, Lu QL, Morgan JE, Partidge T. Differential expression and secretion of alpha 1 anti-trypsin between direct DNA injection and implantation of transfected myoblast. Gene Ther 1999; 6:1021-1029.
21. 21 Day CS, Bosch P, Kasemkijwattana C, Menetrey J, Moreland MS, Fu FH, et al. Use of muscle cells to mediate gene transfer to the bone defect. Tiss Eng 1999; 5:119-125.
22. 22 Dorfman J, Duong M, Zibaitis A, Pelletier MP, Shum-Tim D, Li C, et al. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg 1998; 116:744-751.
23. 23 Irintchev A, Rosenblatt JD, Cullen MJ, Zweyer M, Wernig A. Ectopic skeletal muscles derived from myoblasts implanted under the skin. J Cell Sci 1998; 111:3287-3297.
24. 24 Okano T, Matsuda T. Tissue engineered skeletal muscle: preparation of highly dense, highly orientated hybrid muscular tissue. Cell Transplant 1998; 7:71-82.
25. 25 Kaufmann U, Martin B, Link D, Witt K, Zeitler R, Reinhard S, et al. M-cadherin and its sisters in development of striated muscle. Cell Tiss Res 1999; 296: 191-198. This is an excellent review of the role of cadherins in skeletal and cardiac muscle cells.
26. 26 Sabourin LA, Girgis-Gabardo A, Seale P, Asakura A, Rudnicki MA. Reduced differentiation potential of primary MyoD-/-myogenic cells derived from adult skeletal muscle. J Cell Biol 1999; 144:631-643.
27. 27 Kuschel R, Yablonka-Reuveni Z, Bornemann A. Satellite cells on isolated myofibers from normal and denervated adult rat muscle. J Histochem Cytochem 1999 (in press).
28. 28 Blockhold KJ, Rosenblatt JD, Partridge TA. Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 1998; 21:173-182.
29. 29 Yablonka-Reuveni Z, Seger R, Rivera AJ. Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem 1999; 47:23-42.
30. 30 Yablonka-Reuveni Z, Rivera AJ, Rudnicki MA, Primig M, Anderson JE, Natanson P. The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev Biol 1999; 210:440-455.
31. 31 Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, Allen RE. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 1998; 194:114-128. This is an important paper on the role of HGF in skeletal muscle in vivo.
32. 32 Arnold HH, Winter B, Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet Dev 1998; 8:539-544.
33. 33 Musaro A, Rosenthal N. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor 1. Mol Cell Biol 1999; 19:3115-3124.
34. 34 Garry DJ, Yang Q, Bassel-Duby R, Williams RS. Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev Biol 1997; 188:280-294.
35. 35 Miller JB, Schaefer L, Dominov JA. Seeking muscle stem cells. Curr Top Dev Biol 1999; 43:191-219. This excellent review of myoblast origins in developing and postnatal muscle includes a good discussion of markers for quiescent satellite cells.
36. 36 Lawson-Smith M, McGeachie J. The identification of myogenic cells in skeletal muscle, with emphasis on the use of tritiated thymidine autoradiography and desmin antibodies. J Anat 1998; 192:161-171.
37. 37 Lescaudron L, Creuzet S, Li Z, Paulin D, Fontaine-Perus J. Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants. J Muscle Res Cell Mot 1997; 18:631-641.
38. 38 Mouly V, Decary S, Cooper RN, Barbet JP, Butler-Brown GS. Satellite cell proliferation: starting points and key steps to regeneration and cell mediated therapy. Basic Appl Myol 1997; 7:168-176.
39. 39 Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279:1528-1530. This was the first paper to demonstrate that some skeletal muscle cells can arise from bone-marrow cells an important principle that excited much interest.
40. 40 Bittner RE, Schofer C, Weipoltshammer K, Streubel B, Hauser E, Freilinger M, et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol 1999; 199:391-396.
41. 41 Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999 (in press).
42. 42 Beauchamp J, Morgan J, Page C, Partridge IT. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999; 144:1113-1122.
43. 43 Smythe GM, Fan Y, Grounds MD. Enhanced donor myoblast migration and fusion in normal and dystrophic host muscle. Muscle Nerve 1999 (in press).
44. + or NK1.1 cells. Cell Transpl 1999 (in press).
45. 45 Young HE, Wright R, Mancini ML, Lucas PA, Reagan CR, Black AC. Bioactive factors affect proliferation and phenotypic expression in progenitor and pluripotent stem cells. Wound Rep Regen 1998; 6:65-75.
46. 46 Young HE, Steele TA, Bray RA, Detmer K, Blake LW, Lucas PW, et al. Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC class-1. Proc Soc Exp Biol Med 1999; 221:63-71.
47. 47 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147. The demonstration that human bone marrow contains mesenchymal stem cells has potential clinical implications.
48. 48 Wise CJ, Watt DJ, Jones GE. Conversion of dermal fibroblasts to a myogenic lineage is induced by a soluble factor derived from myoblasts. J Cell Biochem 1996; 61:363-374.
49. 49 Bianco P, Cossu G. Searching for the identity of mesodermal progenitors. Exp Cell Res 1999 (in press).
50. 50 Watt DJ, Jones GE, Goldring K. A factor within myoblast conditioned medium results in a high myogenic conversion in clones of cells derived from the mouse dermis. Cell Transpl 1998; 8:214.
51. 51 Ferrari G, Stornaiuolo A, Sartori S, Cusella-De Angelis G, Mavilio F. Bone marrow transplantation as source of myogenic progenitors: differentiation of stem cells into muscle. Cell Transpl 1999; 8:195.
52. 52 Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103:697-705.
53. 53 Bjornson CRR, Rietz RL, Reynolds BA, Magli C, Vescovi AL. Turning brain into blood: a haematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283:534-537. This is the first demonstration that cells of the haematopoietic lineage can arise from adult neural cells, thus emphasizing the plasticity of such stem cells. This novel observation has important implications (see also [41]).
54. 54 Partridge T. The 'fantastic voyage' of muscle progenitor cells. Nature Med 1998; 4:554-555.
55. 55 Rubin H. Telomerase and cellular lifespan: ending the debate? Nature Biotech 1998. 16:396-397.
56. 56 Metcalf D. Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct? Ann NY Acad Sci 1999; 872:289-303.
57. 57 Blackett N, Gordon M. 'Stochastic': 40 years of use and abuse. Blood 1999; 93:3148-3149.
58. 58 Qu Z, Balkir L, van Deutekom J, Robbins P, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998; 142:1257-1267.
59. 59 Gross J, Morgan J. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 1999; 22:174-185.
60. 60 Yoshida N, Yoshida S, Koishi K, Masuda K, Nabeshima Y-I. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci 1998; 111:769-779.
61. 61 Edom-Vovard F, Mouly V, Barbet JP, Butler-Browne GS. The four populations of myoblasts involved in human limb muscle formation are present from the onset of primary myotube formation. J Cell Sci 1999; 112:191-199.
62. 62 Pagel CN, Partridge TA. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J Neurol Sci 1999; 164:103-116.
63. 63 Dominov JA, Dunn JJ, Miller JB. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expression of muscle cells. J Cell Biol 1989; 142:537-544.
64. 64 Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
65. 65 Solter D, Gearhart J. Putting stem cells to work. Science 1999; 283:1468-1470.
66. 66 Floyd S, Clemens P, Ontell M, Kochanek S, Day C, Yang J, et al. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther 1998; 5:19-30.
67. 67 Kurek JB, Bower JJ, White JD, Muldoon CM, Austin L. Leukaemia inhibitory factor and other cytokines as factors influencing regeneration of skeletal muscle. Basic Appl Myol 1998; 8:347-360.
68. 68 Desgranges P, Barbaud C, Caruelle J-P, Barritault D, Gautron J. A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle. FASEB J 1999; 13:761-766. This paper emphasizies the importance of proteoglycans in skeletal muscle, and shows that they act on many aspects of tissue damage and repair.
69. 69 Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor 1 blocks the age-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998; 26:15603-15607.
70. 70 Kasemkijwattana C, Menetrey J, Day C, Bosch P, Buranapanitkit B, Moreland M, et al. Biologic intervention in muscle healing and regeneration. Sports Med Arthro Rev 1998; 6:95-102.
71. 71 Gilbert T, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, et al. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 1999; 10:1299-1310.
72. 72 Megeney LA, Kablar B, Garret K, Anderson JE, Rudnicki MA. MyoD is required for myogenic stem cell function in adult skeletal muscle. Gene Dev 1996; 10:1173-1183. This paper indicates that MyoD may be crucial for the myogenesis of adult but not developing muscle - this is the first suggestion of such a difference. It also demostrates that mdx/MyoD-null mice have a far more severe pathology than do mdx mice and illustrated the value of such double knockout mice.
73. 73 Li Z, Mericksay M, Agbulut O, Butler-Browne G, Carlsson L, Thornell L-E, et al. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 1997; 139:129-144.
74. 74 Floss T, Arnold H-H, Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev 1997; 11:2040-2051.
75. 75 Rossant J, McMahon A. 'Cre'-ating mouse mutants: a meeting review on conditional mouse genetics. Genes Dev 1999; 13:142-145.
76. 76 Rossi FM, Blau HM. Recent advances in inducible gene expression systems. Curr Opin Biotechnol 1998; 9:451-456.
77. 77 Harvey DM, Caskey CT. Inducible control of gene expression: prospects for gene therapy. Curr Opin Chem Biol 1998; 2:512-518.
78. 78 Blau HM, Rossi MV. Tet B or not Tet B: advances in tetracycline-inducible gene expression. Proc Natl Acad Sci USA 1999; 96:797-799.
79. 79 Gal-Levi R, Leshem Y, Aoki S, Nakamura T, Halevy O. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochem Biophys Acta 1997; 1402:39-51.
80. 80 Miller KJ, Thaloor D, Matteson S, Pavlath GK. Hepatocyte growth factor affects sattelite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol 1999 (in press).
81. 81 Scata KA, Bernard DW, Fox J, Swain JL. FGF receptor availability regulates skeletal myogenesis. Exp Cell Res 1999; 250:10-21.
82. 82 Sheehan SM, Allen RE. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol 1999 (in press).
83. 83 Rescan PY. Identification of a fibroblast growth factor 6 (FGF6) gene in a non-mammalian vertebrate: continuous expression of FGF6 accompanies muscle fiber hyperplasia. Biochim Biophys Acta 1998; 1443:305-314.
84. 84 Carrino DA. Dynamic expression of proteoglycans during skeletal muscle development. Basic Appl Myol 1998; 8:95-106.
85. 85 Brandan E, Larrain J. Heparan sulfate proteoglycans during terminal skeletal muscle cell differentiation: possible functions and regulations of their expression. Basic Appl Myol 1998; 8:107-113.
86. 86 Velleman SG, Mcfarland DC, Coy CS. Skeletal muscle satellite cells: identification of a heparan sulfate proteoglycan. Basic Appl Myol 1998; 8:115-120.
87. 87 Ringlemann B, Roder C, Hallmann R, Maley M, Davies M, Grounds M, et al. Expression of Laminin α1, α2, α4 and α5 chains, fibronectin and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp Cell Res 1999; 246:165-182.
88. 88 Grounds MD, McGeachie JK, Davies MJ, Sorokin L, Maley MAL. The expression of extracellular matrix during adult skeletal muscle regeneration: how the basement membrane, interstitium, and myogenic cells collaborate. Basic Appl Myol 1998; 8:129-142.
89. 89 Kherif S, Dehaupas M, Lafuma C, Fardeau M, Alameddine H. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve. Neuropathol Appl Neurobiol 1998; 24:309-319.
90. 90 Semsarian C, Sutrave P, Richmond DR, Graham RM. Insulin-like growth factor (IGF-1) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell. Biochem J 1999; 339:443-451.
91. 91 Musaro A, McCullagh KJA, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999; 400:581-585.
92. 92 Adams GR, McCue SA. Localized infusion of IGF-1 results in skeletal muscle hypertrophy in rats. J Appl Physiol 1998; 84:1716-1722.
93. 93 Gayan-Ramirez G, Vanderhoydonc F, Verhoeven G, Decramer M. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastronemius. Am J Respir Crit Care Med 1999; 159:283-289.
94. 94 Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 1999; 180:1-9.
95. 95 McPherron AC, Lawler AM, Lee S-J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387:83-90.
96. 96 Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci USA 1998; 95:14938-14943.
97. 97 Hayes A, Williams DA. Examining potential drug therapies for muscular dystrophy utilising the dy/dy mouse: 1. Clenbuterol. J Neurol Sci 1998; 157:122-128.
98. 98 Beiner JM, Jokl P, Cholewicki J, Panjabi MM. The effect of anabolic steroids and corticosteroids healing of muscle confusion injury. Am J Sports Med 1999; 27:2-9.
99. 99 Ben-Dov N, Shefer G, Irintchev A, Wernig A, Oron U, Halevy O. Low-energy laser irradiation affects satellite cell proliferation and differentiation in vitro. Biochim Biophys Acta 1999; 1448:372-380. An interesting effect of lasers on stimulating myoblast proliferation in muscle cultures derived from young (3 weeks) but not older (6 weeks) rats is described.
100. 100 Buliakova NV, Zubkova SM, Azarova VS, Varakina NI, Mikhailik LV. Regeneration of irradiated, mechanically damaged rat skeletal muscle after exposure to infrared laser irradiation. Dokl Akad Nauk 1998; 359:123-127.
101. 101 McIntosh L, Granberg KE, Briere KM, Anderson JE. Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair. NMR Biomed 1998; 11:1-10.